USE OF MISOPROSTOL IN ABORTION ON MEDICAL GROUNDS - OUR CLINICAL EXPERIENCE

被引:0
|
作者
Zhekov, Zhivko [1 ,2 ]
Radeva, Svetlana [1 ,3 ]
机构
[1] Specialized Hosp Obstet & Gynecol Act Treatment Va, Dept Gynecol, Varna, Bulgaria
[2] Med Univ Varna, Dept Obstet & Gynecol, 150 Tcar Osvoboditel Blvd, Varna 5000, Bulgaria
[3] Med Univ Varna, Fac Publ Hlth, Dept Hlth care, Varna, Bulgaria
来源
JOURNAL OF IMAB | 2024年 / 30卷 / 02期
关键词
malformations; prenatal diagnosis; Commission medical abortion; Misoprostol; therapeutic scheme; MIFEPRISTONE;
D O I
10.5272/jimab.2024302.5545
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose . In clinical practice in hospital conditions, the preferred choice of behavior regarding fetal anomalies is to perform a medical abortion after the opinion of a specialized committee in the hospital. There are no observations conducted by other authors on abortions related to termination of pregnancy for medical reasons at a different time. The team conducts its observation in hospital conditions. Material/Methods: Conducted own retrospective study for the period January 2021 - February 2024 with the participation of 45 patients who went through a pregnancy termination committee on medical grounds. All women who passed through the committee for medically indicated abortion, in which fetal anomalies incompatible with life or severely debilitating were found, were examined. Women are at different stages of pregnancy, age, education, number of pregnancies and births, concomitant diseases, a type of test to diagnose abnormalities in the fetus (invasive and non-invasive). The type of abnormality that is the cause of an abortion on medical grounds has also been investigated. The dosage applied is- 1st tablet of 400 mg Misoprostol per vagine, second and third tablets in 3 hours sub buccal, the maximum dose is 5 tablets in 24 hours or 2000 microgram Misoprostol. Results . For 88,9% of the cases, they have a positive opinion of the commission in the hospital structure, and 11,1% have a refusal. Group matching of patients was performed by education and whether they had good outpatient follow-up, regardless of the duration of pregnancy. Patients with higher education had better outpatient follow-up ( chi 2=15.497, p=0.000) than those with secondary and primary education. There was a significant association between the dosing regimen and pregnancy severity; the relationship between the two -dose regimen was significant ( chi 2=53.862, p=0.000), and the three -dose regimen was highly successful in 73.3% of cases. Conclusion. The correct choice of method of application of the therapeutic regimen requires preliminary and detailed medical preparation of the patient and good clinical experience of the treating doctor. The applied therapeutic approach reduces the risk to the patient and has a rapid recovery period. Early and timely diagnosis has an important informative value.
引用
收藏
页码:5545 / 5551
页数:7
相关论文
共 50 条
  • [41] Medical abortion by mifepristone with oral versus vaginal misoprostol
    Jyothi, Shetty
    Pallavi, M. N. V.
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2006, 56 (06): : 529 - 531
  • [42] Factors related to completeness of medical abortion with mifepristone and misoprostol
    Jiang, Wen-Xiao
    He, Fang-Fang
    Shen, Qi
    Tao, Xue-Jiao
    Zhao, Chu-Chu
    Shen, Zhao-Jun
    Zhu, Xue-Qiong
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2017, 80 (02) : 96 - 102
  • [43] Risk factors for unsuccessful medical abortion with mifepristone and misoprostol
    Haimov-Kochman, Ronit
    Arbel, Revital
    Sciaky-Tamir, Yael
    Brzezinski, Amnon
    Laufer, Neri
    Yagel, Simcha
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2007, 86 (04) : 462 - 466
  • [44] OVULATION RESUMPTION AFTER MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL
    Sober, S.
    Ratcliffe, S.
    Creinin, M. D.
    Schreiber, C.
    CONTRACEPTION, 2010, 82 (02) : 207 - 207
  • [45] Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria
    Okonofua, Friday
    Shittu, Oladapo
    Shochet, Tara
    Diop, Ayisha
    Winikoff, Beverly
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2014, 125 (01) : 49 - 52
  • [46] Complications of self-induced medical abortion with misoprostol
    Rouzi, AA
    SAUDI MEDICAL JOURNAL, 2003, 24 (02) : 228 - 228
  • [47] Home administration of misoprostol for early medical abortion in India
    Bracken, Hillary
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 108 (03) : 228 - 232
  • [48] Mifepristone With Buccal Misoprostol for Medical Abortion A Systematic Review
    Chen, Melissa J.
    Creinin, Mitchell D.
    OBSTETRICS AND GYNECOLOGY, 2015, 126 (01): : 12 - 21
  • [50] Ovulation resumption after medical abortion with mifepristone and misoprostol
    Schreiber, Courtney A.
    Sober, Stephanie
    Ratcliffe, Sarah
    Creinin, Mitchell D.
    CONTRACEPTION, 2011, 84 (03) : 230 - 233